150 related articles for article (PubMed ID: 34851805)
21. Hypoxia-related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosis.
Harada M; Kotani H; Iida Y; Tanino R; Minami T; Komohara Y; Yoshikawa K; Uemura H
Cancer Sci; 2024 May; 115(5):1405-1416. PubMed ID: 38413363
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase 9 expression increases with vascular endothelial growth factor-targeted therapy and is predictive of outcome in metastatic clear cell renal cancer.
Stewart GD; O'Mahony FC; Laird A; Rashid S; Martin SA; Eory L; Lubbock AL; Nanda J; O'Donnell M; Mackay A; Mullen P; McNeill SA; Riddick AC; Aitchison M; Berney D; Bex A; Overton IM; Harrison DJ; Powles T
Eur Urol; 2014 Nov; 66(5):956-63. PubMed ID: 24821582
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors.
Ding J; Zheng Y; Zhu F; Wang M; Fang L; Li H; Tian H; Liu Y; Wang G; Zheng J; Chai D
Int Immunopharmacol; 2023 Oct; 123():110722. PubMed ID: 37573687
[TBL] [Abstract][Full Text] [Related]
24. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience.
Lamers CH; Sleijfer S; Vulto AG; Kruit WH; Kliffen M; Debets R; Gratama JW; Stoter G; Oosterwijk E
J Clin Oncol; 2006 May; 24(13):e20-2. PubMed ID: 16648493
[No Abstract] [Full Text] [Related]
25. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
Tostain J; Li G; Gentil-Perret A; Gigante M
Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus vaccine therapy with CD137L promotes CD8
Ding J; Jiang N; Zheng Y; Wang J; Fang L; Li H; Yang J; Hu A; Xiao P; Zhang Q; Chai D; Zheng J; Wang G
Pharmacol Res; 2022 Jan; 175():106034. PubMed ID: 34915126
[TBL] [Abstract][Full Text] [Related]
29. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
30. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
31. The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness.
Panelli MC; Wang E; Marincola FM
Clin Cancer Res; 2005 May; 11(10):3601-3. PubMed ID: 15897553
[No Abstract] [Full Text] [Related]
32. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
Parks SK; Cormerais Y; Durivault J; Pouyssegur J
Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
[TBL] [Abstract][Full Text] [Related]
33. Concomitant tumor and autoantigen vaccination supports renal cell carcinoma rejection.
Herbert N; Haferkamp A; Schmitz-Winnenthal HF; Zöller M
J Immunol; 2010 Jul; 185(2):902-16. PubMed ID: 20548033
[TBL] [Abstract][Full Text] [Related]
34. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors.
Heiser A; Maurice MA; Yancey DR; Coleman DM; Dahm P; Vieweg J
Cancer Res; 2001 Apr; 61(8):3388-93. PubMed ID: 11309297
[TBL] [Abstract][Full Text] [Related]
35. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells.
Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y
Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740
[TBL] [Abstract][Full Text] [Related]
36. Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant.
Wang Y; Wang XY; Subjeck JR; Kim HL
Mol Cancer Ther; 2008 Dec; 7(12):3867-77. PubMed ID: 19074859
[TBL] [Abstract][Full Text] [Related]
37. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR].
Jiang YD; Zheng SB; Wang ZH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):99-101. PubMed ID: 14724112
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase IX expression in clear cell renal cell carcinoma and normal tissues: experiences from (radio) immunotherapy.
Brouwers AH; Mulders PF; Oyen WJ
J Clin Oncol; 2008 Aug; 26(22):3808-9; author reply 3811-2. PubMed ID: 18669472
[No Abstract] [Full Text] [Related]
39. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo.
Chang DK; Moniz RJ; Xu Z; Sun J; Signoretti S; Zhu Q; Marasco WA
Mol Cancer; 2015 Jun; 14():119. PubMed ID: 26062742
[TBL] [Abstract][Full Text] [Related]
40. [MN/CA IX antigen as a potential target for renal cell carcinoma].
Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]